03.28.2018 - By NEJM Group
There simply isn’t enough evidence to sustain its continued use in asymptomatic men, argues our guest. Dr. Jason Profetto, senior author on an Annals of Family Medicine meta-analysis. Links: Annals of Family Medicine abstract Physician’s First Watch coverage